Oncology One

Homepage: oncologyone.com.au

Alternate names: CTxONE, Oncology One Pty Ltd

ROR: 0158h9805

OpenAlex ID: I4405279226

Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer

2023 · Shikhar Sharma, Chi-Yeh Chung, et al. · Cell chemical biology · 82

KIF18A inhibition: the next big player in the search for cancer therapeutics

2024 · Ain Syafiza Mohd Amin, Sarah Eastwood, et al. · Cancer and Metastasis Reviews · 16

Works count: 2

Citation count: 196